Comparison between ANG Lifesciences IPO and Lexus Granito IPO.
ANG Lifesciences IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Lexus Granito IPO is a SME Bookbuilding proposed to list at NSE SME.
| ANG Lifesciences IPO | Lexus Granito IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Bookbuilding |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Oneview Corporate Advisors Pvt.Ltd. | Pantomath Capital Advisors Pvt.Ltd. |
| Registrar | Bigshare Services Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Guiness Securities Ltd. | Pantomath Stock Brokers Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ANG Lifesciences IPO is up to ₹11.39 Cr whereas the issue size of the Lexus Granito IPO is up to ₹24.57 Cr. The final issue price of ANG Lifesciences IPO is ₹80.00 per share and of Lexus Granito IPO is ₹45.00 per share.
| ANG Lifesciences IPO | Lexus Granito IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹41.00 per share | |
| Issue Price (Upper) | ₹45.00 per share | |
| Issue Price (Final) | ₹80.00 per share | ₹45.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | 3000 shares |
| Fresh Issue Size | 14,24,000 shares | 54,60,000 shares |
| Fresh Issue Size (Amount) | up to ₹11.39 Cr | up to ₹24.57 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 14,24,000 shares | 54,60,000 shares |
| Issue Size Total (Amount) | up to ₹11.39 Cr | up to ₹24.57 Cr |
ANG Lifesciences IPO opens on Aug 29, 2017, while Lexus Granito IPO opens on Aug 09, 2017. The closing date of ANG Lifesciences IPO and Lexus Granito IPO is Aug 31, 2017, and Aug 11, 2017, respectively.
| ANG Lifesciences IPO | Lexus Granito IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Aug 29, 2017 | Aug 09, 2017 |
| Issue Close | Aug 31, 2017 | Aug 11, 2017 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Sep 08, 2017 | Aug 23, 2017 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
ANG Lifesciences IPO P/E ratio is , as compared to Lexus Granito IPO P/E ratio of .
| ANG Lifesciences IPO | Lexus Granito IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | ||||||
| Promoter Shareholding (Post-Issue) | ||||||
| P/E Ratio | ||||||
| Market Cap | ₹41.47 Cr. | ₹86.36 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW |
In the ANG Lifesciences IPO Retail Individual Investors (RII) are offered 7,12,000 shares while in Lexus Granito IPO retail investors are offered 7,12,000 shares. Qualified Institutional Buyers (QIB) are offered in ANG Lifesciences IPO and 16,38,000 shares in Lexus Granito IPO.
| ANG Lifesciences IPO | Lexus Granito IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 76,800 shares | 3,00,000 shares |
| QIB | 16,38,000 shares | |
| NII | 7,12,000 shares | 19,11,000 shares |
| RII | 7,12,000 shares | 19,11,000 shares |
| Employee | ||
| Others | ||
| Total | 14,24,000 shares | 54,60,000 shares |
ANG Lifesciences IPO subscribed 8.25x in total, whereas Lexus Granito IPO subscribed 37.41x.
| ANG Lifesciences IPO | Lexus Granito IPO | |
|---|---|---|
| QIB (times) | 3.22x | |
| NII (times) | 5.13x | 65.12x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 11.36x | 39.01x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 8.25x | 37.41x |
